Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
LAND SECURITIES GROUP PLC ORD 10 2/3P, BURFORD CAPITAL LIMITED ORD NPV (DI), SMITH & NEPHEW PLC ORD USD0.20, BIDSTACK GROUP PLC ORD 0.5P, LLOYDS BANKING GROUP PLC ORD 10P, BARCLAYS PLC ORD 25P
FTSE 100, DAX Index, Euro Stoxx 50, S&P 500, Nasdaq Composite, Nikkei 225
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Bottom of the range looks a good place to buy GSK. Underperforming though and needs some impetus for share price growth.
Support 4900. Long term prospek sebab vaccine player. Distribute vaccine Sinovac. Cl below 4000.
Pre market price at 98.9 is above 95 resistance after covid-19 vaccine test results. Also all time high, which makes it bullish
Will MRNA break 86.7 based on it's Covid-19 vaccine work? NOTE: Although not a recommendation, if you like my work, please donate a few coins. Thanks.
Pressure is building and a breakout could be imminent. It's taken 6 years from May 2013 where the high was 1816 Needs substantive news to make the push over the 1750s
Really like this chart & can see a good rise after MM's pull price down to support at 74.4p - also 200ma weekly at 72p Best to scale in near the support level but watch out if RSI support level is not respected or 200ma as well, be ready to move out if so.
Prudent Drug Discovery Company Low market cap ( appox £13m at time of writing ). Issues shares very rarely ( last placing nearly four years ago ). Has material interest in its work from larger partners ( Pharmaxis ). Sold interest in LOXL2 programme for £5m to Pharmaxis in December. Pharmaxis continues to fund and develop LOXL2 inhibitors and Synairgen retains...